SightfileU.S. market data from official filings

CADRE HLDGS INC (CDRE)

Name: CADRE HLDGS INC (CDRE) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001860543 · EDGAR filings · Updated 2026-06-23

CADRE HLDGS INC (CDRE) has reported institutional ownership of 74.4%, with 168 institutional managers holding positions valued at $974.6M per the latest 13F reporting period.

Institutional ownership

74.4%

Institutional managers

168

Reported 13F value

$974.6M

Insider activity

42 trans.

−$82.4M net selling

Latest updates

2026-06-23 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — SCHEDULE 13D/A filed
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CADRE HLDGS INC has 168 institutional holders and institutional ownership of 74.4%.

Insider activity

Insiders reported 42 transactions (0 buys, 21 sells) across 3 reporting insiders, with a net reported value of −$82.4M.

Related companies

STAAR SURGICAL CO (STAA) · TELADOC HEALTH INC (TDOC) · PACIRA BIOSCIENCES INC COM (PCRX) · ARRIVENT BIOPHARMA INC (AVBP) · NOVAVAX INC (NVAX) · BIOLIFE SOLUTIONS INC COM NEW (BLFS)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-23.